Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pingyangmycin plus fibrin glue for head and neck venous malformations
ChiCTR2100053242Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems, Antimicrobial Peptides → Native Peptides → Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pingyangmycin and tachosil in venous malformation (VM), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Cure rate, Incidence of adverse reactions and 1 more. Started Jun 2022; status: recruiting.
02
Drugs
pingyangmycintachosil
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on ChiCTR2100053242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053242.